Join the Diabetes, Type 1 group to help and get support from people like you.
Diabetes, Type 1 News (Page 2)
Related terms: Insulin Dependent Diabetes, Juvenile onset diabetes, Type 1 Diabetes, Type One, Type 1, Type 1 Diabetes Mellitus
FDA Approves Merilog, First Rapid-Acting Insulin Biosimilar for Patients With Diabetes
WEDNESDAY, Feb. 19, 2025 – The U.S. Food and Drug Administration has approved Merilog (insulin-aspart-szjj) as a biosimilar to Novolog (insulin aspart) for adults and pediatric patients with...
FDA Approves Merilog, First Rapid-Acting Insulin Biosimilar for Patients With Diabetes
WEDNESDAY, Feb. 19, 2025 – The U.S. Food and Drug Administration has approved Merilog (insulin-aspart-szjj) as a biosimilar to Novolog (insulin aspart) for adults and pediatric patients with...
Wrong Smartphone Settings Can Lead to Missed Alerts From Linked Diabetes Devices
TUESDAY, Feb. 11, 2025 – The U.S. Food and Drug Administration is urging all patients with smartphone-compatible diabetes devices to check their phone configurations to ensure all safety alerts are...
Body Weight Cycling Tied to Increased Risk for Renal Events in Type 1 Diabetes
MONDAY, Feb. 10, 2025 – For individuals with type 1 diabetes, intraindividual body weight variability, or body weight cycling, is associated with an increased risk for renal events, according to a...
FDA Approves Susvimo for Diabetic Macular Edema
WEDNESDAY, Feb. 5, 2025 -- The U.S. Food and Drug Administration has approved Susvimo (ranibizumab) 100 mg/mL for treating diabetic macular edema. Susvimo is the first and only FDA-approved treatment ...
Diabetic 'Yo-yo' Dieting Can Harm Kidneys
WEDNESDAY, Feb. 5, 2025 – “Yo-yo” dieting – repeatedly losing and gaining weight – can significantly increase risk of kidney disease among people with type 1 diabetes, a new study warns. Diabetics ...
Continuous Glucose Monitoring Can Predict Microvascular Complications in Type 1 Diabetes
WEDNESDAY, Jan. 22, 2025 – Fourteen-day continuous glucose monitoring (CGM) traces added to Diabetes Control and Complications Trial (DCCT) data can predict microvascular diabetes complications...
Fecal Transplants May Help People Who Have Diabetes, Gut Issues, Study Says
Monday, Jan. 13, 2025 – A fecal transplant could help people whose type 1 diabetes has fouled up their digestive system. Swallowing a handful of capsules filled with donor feces helped ease gut...
Fecal Microbiota Transplant Beneficial in T1DM With Bowel Symptoms
MONDAY, Jan. 13, 2025 – For patients with type 1 diabetes with moderate-to-severe gastrointestinal symptoms, fecal microbiota transplantation (FMT) is safe and improves clinical outcomes, according...
Technosphere Insulin + Insulin Degludec Noninferior to Usual Care in T1DM
MONDAY, Dec. 16, 2024 – For adults with type 1 diabetes, a regimen of inhaled Technosphere insulin (TI) plus insulin degludec is noninferior to usual care for glycemic control, according to a study...
Layperson-Delivered Empathetic Intervention Ups Glycemic Control
FRIDAY, Dec. 13, 2024 – A telephone-based layperson-delivered empathetic engagement is beneficial for improving glycemic control in patients with diabetes with low income, according to a study...
Automated Insulin Delivery System Improves Glycemic Control in Youth
THURSDAY, Dec. 12, 2024 – Initiation of an automated insulin delivery (AID) system improves glycemic control in children and adolescents with type 1 diabetes (T1D), according to a study published in...
Novo Nordisk to Lower U.S. List Prices for Tresiba and Fiasp by More Than 70%
PLAINSBORO, N.J., Dec. 05, 2024 – Novo Nordisk today announced plans to reduce the US list prices of two insulin products by more than 70% to better meet the needs of people living with diabetes....
Burden of Diabetes, Untreated Diabetes Increased From 1990 to 2022
FRIDAY, Nov. 15, 2024 – The global burden of diabetes and untreated diabetes increased from 1990 to 2022, according to a study published online Nov. 13 in The Lancet. Bin Zhou, Ph.D., from Imperial...
More Than 800 Million People Worldwide Now Have Diabetes
THURSDAY, Nov. 14, 2024 – Fourteen percent of the world's people – more than 800 million – now have diabetes, a doubling of the global rate for the blood sugar disease since 1990, new statistics...
Further information
Related condition support groups
Related drug support groups
Lantus, Lantus Solostar, Humalog, Novolog, insulin glargine, insulin lispro, Tresiba, Levemir, insulin degludec, Humulin N